HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 131 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $305,000 | -64.2% | 18,959 | -59.6% | 0.00% | -57.1% |
| Q3 2018 | $852,000 | +76.0% | 46,876 | +63.3% | 0.01% | +133.3% |
| Q2 2018 | $484,000 | -73.5% | 28,700 | -69.2% | 0.00% | -76.9% |
| Q1 2018 | $1,823,000 | +91.9% | 93,059 | +98.4% | 0.01% | +85.7% |
| Q4 2017 | $950,000 | +39.5% | 46,898 | +19.6% | 0.01% | +75.0% |
| Q3 2017 | $681,000 | +52.7% | 39,220 | +12.7% | 0.00% | +33.3% |
| Q2 2017 | $446,000 | -61.6% | 34,800 | -48.0% | 0.00% | -72.7% |
| Q4 2015 | $1,160,000 | -46.6% | 66,919 | -58.7% | 0.01% | -50.0% |
| Q3 2015 | $2,174,000 | +136.0% | 161,900 | +296.8% | 0.02% | +144.4% |
| Q2 2015 | $921,000 | +151.6% | 40,800 | +59.4% | 0.01% | +200.0% |
| Q1 2015 | $366,000 | -70.4% | 25,600 | -79.5% | 0.00% | -88.0% |
| Q2 2014 | $1,236,000 | – | 125,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,084,118 | $61,686,285 | 7.80% |
| SNYDER CAPITAL MANAGEMENT L P | 3,983,814 | $226,679,017 | 5.12% |
| First Light Asset Management, LLC | 923,119 | $52,525,471 | 4.88% |
| Redwood Investments, LLC | 441,809 | $25,138,932 | 3.37% |
| BERNZOTT CAPITAL ADVISORS | 444,728 | $25,305,023 | 3.27% |
| DOHENY ASSET MANAGEMENT /CA | 46,050 | $2,620 | 3.04% |
| Crawford Lake Capital Management, LLC | 42,171 | $2,399,530 | 2.75% |
| 2Xideas AG | 416,586 | $23,703,743 | 2.51% |
| Granite Investment Partners, LLC | 902,882 | $51,373,986 | 2.14% |
| HighMark Wealth Management LLC | 41,790 | $2,377,851 | 1.79% |